Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Reed

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Current Psychiatry Reports|September 12, 2014
Genetics of opiate addictionBrian Reed, Eduardo R Butelman, Vadim Yuferov, et al.
Open Access Emergency Medicine : OAEM|August 5, 2021
Randomized Controlled Trial of a Novel Silicone Device for the Packing of Cutaneous Abscesses in the Emergency Department: A Pilot StudyAaron Brody, John Gallien, Brian Reed, et al.
ACS Chemical Neuroscience|July 18, 2019
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo ResponsesAmelia D Dunn, Brian Reed, Jose Erazo, et al.
Human Psychopharmacology|February 13, 2020
Neuroendocrine effects of naltrexone versus nalmefene in humansEduardo R Butelman, Rebecca S Fry, Rachel Kimani, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 2017
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine DependenceBrian Reed, Eduardo R Butelman, Rebecca S Fry, et al.
Psychopharmacology|July 26, 2012
Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptorsKatharine M Seip-Cammack, Brian Reed, Yong Zhang, et al.
Plos One|May 23, 2012
Reph, a regulator of Eph receptor expression in the Drosophila melanogaster optic lobeRichard E Dearborn, Yong Dai, Brian Reed, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 10, 2018
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine DependenceBrian Reed, Eduardo R Butelman, Rebecca S Fry, et al.
Psychopharmacology|January 10, 2020
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in ratMarta Valenza, Kyle A Windisch, Eduardo R Butelman, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 9, 2020
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over timeVarun Vohra, Andrew King, Sydney Daviskiba, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Current Psychiatry Reports|September 12, 2014
Genetics of opiate addictionBrian Reed, Eduardo R Butelman, Vadim Yuferov, et al.
Open Access Emergency Medicine : OAEM|August 5, 2021
Randomized Controlled Trial of a Novel Silicone Device for the Packing of Cutaneous Abscesses in the Emergency Department: A Pilot StudyAaron Brody, John Gallien, Brian Reed, et al.
ACS Chemical Neuroscience|July 18, 2019
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo ResponsesAmelia D Dunn, Brian Reed, Jose Erazo, et al.
Human Psychopharmacology|February 13, 2020
Neuroendocrine effects of naltrexone versus nalmefene in humansEduardo R Butelman, Rebecca S Fry, Rachel Kimani, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 2017
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine DependenceBrian Reed, Eduardo R Butelman, Rebecca S Fry, et al.
Psychopharmacology|July 26, 2012
Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptorsKatharine M Seip-Cammack, Brian Reed, Yong Zhang, et al.
Plos One|May 23, 2012
Reph, a regulator of Eph receptor expression in the Drosophila melanogaster optic lobeRichard E Dearborn, Yong Dai, Brian Reed, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 10, 2018
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine DependenceBrian Reed, Eduardo R Butelman, Rebecca S Fry, et al.
Psychopharmacology|January 10, 2020
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in ratMarta Valenza, Kyle A Windisch, Eduardo R Butelman, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 9, 2020
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over timeVarun Vohra, Andrew King, Sydney Daviskiba, et al.
Pageof 7